Summary
This article discusseds a post hoc analysis of data from the phase 3 Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus study [BLOOM-DM; NCT00603291], concerning the effects of the weight loss drug lorcaserin in patients with type 2 diabetes mellitus who are overweight or obese.
- Diabetes & Endocrinology Clinical Trials
- Obesity
- Diabetes Mellitus
- Nutrition Clinical Trials
- Diabetes & Endocrinology Clinical Trials
- Endocrinology
- Diabetes & Metabolic Syndrome
- Obesity
- Diabetes Mellitus
- Nutrition Clinical Trials
- © 2014 MD Conference Express®
Tools
Lorcaserin May Regulate Glucose Homeostasis Independent of Weight Loss
Permalink:
Table of contents
Cited By...
- No citing articles found.